HalioDx organizes a webinar on "Clinical utility of Immunoscore® in colon cancer" on October 17, 2017 5:30 PM CET
Speaker: Marc Van Den Eynde, MD, PhD, Digestive oncology, Cliniques universitaires St-Luc, will share with you his view on the role of Immunoscore® Colon* today for Stage II and Stage III Colon Cancer patients.
Moderator: Fabienne Hermitte, PhD, VP Medical Affairs, HalioDx
- Immunoscore® Colon: History & utility
- Latest news at ASCO & ESMO on Immunoscore® Colon
- Why Immunoscore® Colon for Stage II & Stage III patients
- Immunoscore® tomorrow